drugset / Trial / NCT02571998

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

NCT02571998

Phase 2 Completed 320 enrolled Maruho Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary objective of this study is to evaluate the safety and efficacy of Omiganan (CLS001) topical gel compared to vehicle topical gel applied once daily for 12 weeks in female subjects with moderate to severe inflammatory acne vulgaris.

Timeline

Start
2015-10
Primary completion
2016-08
Completion
2016-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Omiganan Protein / enzyme biologic Topical

Indications